Leber's Hereditary Optic Neuropathy (LHON) is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Leber's hereditary optic neuropathy (LHON) is a rare maternally inherited mitochondrial disorder that primarily affects the optic nerves, leading to sudden, painless vision loss. It is one of the most common mitochondrial diseases, with an estimated prevalence of 1 in 30,000 to 1 in 50,000 individuals worldwide[1]. [@newman2021]
Epidemiology
Prevalence: 1 in 30,000–50,000 people[1]
Age of onset: Typically 15–35 years (range 4–80 years)
Sex bias: 80–90% of affected individuals are male[1]
Inheritance: Maternal (mitochondrial) inheritance — only females transmit the mutation
Genetics
LHON is caused by pathogenic mutations in mitochondrial DNA (mtDNA) that affect oxidative phosphorylation complex I function[7]. The primary mutations are: [@carelli2022]
| Mutation | Gene | Frequency | [@yuwaiman2023] |----------|------|-----------| [@pfeffer2022] | m.11778G>A | MT-ND4 | ~60% of cases | [@gueven2021] | m.3460G>A | MT-ND1 | ~30% of cases | [@talman2023] | m.14484T>C | MT-ND6 | ~6–10% of cases | [@watanabe2022]
Penetrance
...
Leber's Hereditary Optic Neuropathy (LHON)
Overview
Leber's Hereditary Optic Neuropathy (LHON) is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Leber's hereditary optic neuropathy (LHON) is a rare maternally inherited mitochondrial disorder that primarily affects the optic nerves, leading to sudden, painless vision loss. It is one of the most common mitochondrial diseases, with an estimated prevalence of 1 in 30,000 to 1 in 50,000 individuals worldwide[1]. [@newman2021]
Epidemiology
Prevalence: 1 in 30,000–50,000 people[1]
Age of onset: Typically 15–35 years (range 4–80 years)
Sex bias: 80–90% of affected individuals are male[1]
Inheritance: Maternal (mitochondrial) inheritance — only females transmit the mutation
Genetics
LHON is caused by pathogenic mutations in mitochondrial DNA (mtDNA) that affect oxidative phosphorylation complex I function[7]. The primary mutations are: [@carelli2022]
| Mutation | Gene | Frequency | [@yuwaiman2023] |----------|------|-----------| [@pfeffer2022] | m.11778G>A | MT-ND4 | ~60% of cases | [@gueven2021] | m.3460G>A | MT-ND1 | ~30% of cases | [@talman2023] | m.14484T>C | MT-ND6 | ~6–10% of cases | [@watanabe2022]
Penetrance
Only approximately 40–50% of males and 8–12% of females with a pathogenic mtDNA mutation develop clinical symptoms. This incomplete penetrance suggests that nuclear genetic modifiers and environmental factors influence disease expression[2]. [@larsson2021]
Clinical Features
Core Symptoms
Painless acute vision loss — typically painless, sudden onset
Central vision loss — initially affects central vision, progressing to legal blindness
Color vision deficits — red-green color vision impaired early
Scotomas — central or centrocecal blind spots
Disease Course
Acute phase (weeks to months): Vision loss progresses rapidly
Chronic phase: Stabilization 4–6 months after onset
Recovery phase: 10–20% of patients experience some spontaneous visual improvement, particularly with the m.14484T>C mutation
Extraocular Manifestations
Although primarily an optic neuropathy, LHON can be associated with:
Cardiac conduction defects
Tremor
Peripheral neuropathy
Movement disorders (rare)
Pathophysiology
Molecular Mechanisms
Complex I dysfunction: Primary mtDNA mutations impair NADH:ubiquinone oxidoreductase activity[7]
ATP depletion: Reduced oxidative phosphorylation leads to insufficient neuronal ATP